BridgeBio Pharma, (Germany) Alpha and Beta Analysis
| 2CL Stock | EUR 64.46 2.00 3.01% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BridgeBio Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in BridgeBio Pharma, over a specified time horizon. Remember, high BridgeBio Pharma,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BridgeBio Pharma,'s market risk premium analysis include:
Beta (0.24) | Alpha 0.25 | Risk 2.23 | Sharpe Ratio 0.17 | Expected Return 0.38 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BridgeBio |
BridgeBio Pharma, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BridgeBio Pharma, market risk premium is the additional return an investor will receive from holding BridgeBio Pharma, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BridgeBio Pharma,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BridgeBio Pharma,'s performance over market.| α | 0.25 | β | -0.24 |
BridgeBio Pharma, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BridgeBio Pharma,'s Buy-and-hold return. Our buy-and-hold chart shows how BridgeBio Pharma, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BridgeBio Pharma, Market Price Analysis
Market price analysis indicators help investors to evaluate how BridgeBio Pharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BridgeBio Pharma, shares will generate the highest return on investment. By understating and applying BridgeBio Pharma, stock market price indicators, traders can identify BridgeBio Pharma, position entry and exit signals to maximize returns.
BridgeBio Pharma, Return and Market Media
The median price of BridgeBio Pharma, for the period between Fri, Nov 7, 2025 and Thu, Feb 5, 2026 is 62.82 with a coefficient of variation of 6.66. The daily time series for the period is distributed with a sample standard deviation of 4.1, arithmetic mean of 61.56, and mean deviation of 3.37. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | How dovish Fed policy supports BridgeBio Pharma Inc. stock - Weekly Trend Summary Smart Money Movement Alerts - newser.com | 11/14/2025 |
2 | How Investors May Respond To BridgeBio Pharma Strong Attruby Sales, Wider Losses, And CEO Stock Sale - simplywall.st | 12/10/2025 |
3 | BridgeBio Pharma stock hits all-time high at 77.32 By Investing.com - Investing.com Nigeria | 12/22/2025 |
4 | The biotech scorecard for the first quarter 26 stock-moving events to watch - statnews.com | 01/05/2026 |
5 | A Look At BridgeBio Pharma Valuation After New ATTR-CM, LGMD2IR9 And TTR Antibody Updates - simplywall.st | 01/14/2026 |
6 | BridgeBio Pharma Issues New Convertible Notes and Repurchases Stock - TipRanks | 01/21/2026 |
7 | BridgeBio Pharma stock initiated with Overweight rating by Barclays - Investing.com | 01/28/2026 |
8 | BridgeBio Pharma, Inc. Stock Analysis Eyeing a 20.55 percent Upside Amidst Robust Revenue Growth - DirectorsTalk Interviews | 02/02/2026 |
About BridgeBio Pharma, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BridgeBio or other stocks. Alpha measures the amount that position in BridgeBio Pharma, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BridgeBio Pharma, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BridgeBio Pharma,'s short interest history, or implied volatility extrapolated from BridgeBio Pharma, options trading.
Build Portfolio with BridgeBio Pharma,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out BridgeBio Pharma, Analysis, BridgeBio Pharma, Valuation, BridgeBio Pharma, Correlation, BridgeBio Pharma, Hype Analysis, BridgeBio Pharma, Volatility, BridgeBio Pharma, Price History and analyze BridgeBio Pharma, Performance. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
BridgeBio Pharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.